For research use only. Not for therapeutic Use.
C3a receptor agonist 1 (compound benzeneacetamide) is a potent C3a receptor agonist. C3a receptor agonist 1 has the potential for the research of acute inflammation[1].
Catalog Number | R067010 |
CAS Number | 944997-60-8 |
Synonyms | 2-cyclohexyl-2-phenyl-N-[1-(3-pyridin-3-ylpropanoyl)piperidin-4-yl]acetamide |
Molecular Formula | C27H35N3O2 |
Purity | ≥95% |
InChI | InChI=1S/C27H35N3O2/c31-25(14-13-21-8-7-17-28-20-21)30-18-15-24(16-19-30)29-27(32)26(22-9-3-1-4-10-22)23-11-5-2-6-12-23/h1,3-4,7-10,17,20,23-24,26H,2,5-6,11-16,18-19H2,(H,29,32) |
InChIKey | RMFOYNMWESQGBZ-UHFFFAOYSA-N |
SMILES | C1CCC(CC1)C(C2=CC=CC=C2)C(=O)NC3CCN(CC3)C(=O)CCC4=CN=CC=C4 |
Reference | [1]. Trent Martin Woodruff, et al. Prevention and treatment of acute inflammatory conditions. WO2012174591A1. |